Description
Retatrutide is an innovative, once‑weekly injectable designed to transform weight management and metabolic health by activating GIP, GLP‑1, and glucagon.
How It Works
- GLP‑1 Agonism: Reduces appetite and improves glycemic control.
- GIP Agonism: Enhances weight loss and glycemic benefits.
- Glucagon Agonism: Increases energy expenditure and reduces liver fat.
- Triple‑Action: Targets appetite, energy use, glucose metabolism, and liver fat.
Key Benefits
- Weight Loss: Up to 20% body weight reduction in high‑dose groups.
- Blood Sugar Control: Rapid, sustained improvements in A1C levels.
- Liver Fat Reduction: Significant decreases in NAFLD subgroups.
- Tolerability: Generally well‑tolerated with mild, transient side effects.
Usage
- Once or bi‑weekly subcutaneous injection with titration.
- Part of a comprehensive weight‑management program including diet and activity.
